US$ 24.75
semaglutide intestinal blockage Wegovy class has higher GI side effect risk than older weight loss drug in study A potentially serious adverse effect
Description
Key points: Both medications cause similar gastrointestinal side effects, most commonly nausea, diarrhoea, and constipation Side effects tend to occur early in treatment and improve over time Tirzepatide appears to have lower discontinuation rates due to side effects than liraglutide Liraglutide has a longer safety track record (approved 2015 vs 2023 for tirzepatide) Dosing and practical differences Injection frequency One of the most significant practical differences is how often you inject

So, microdoses apparently refer to much smaller amounts

The net effect should be substantially improved muscle retention compared to Retatrutide alone

Most side effects are mild to moderate
